source Post navigation Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial – Nature.com Philadelphia jail withheld insulin from a diabetic inmate who died, lawsuit says – ABC News